COM-IT-2 Immunotherapy combined with extensive radiotherapy for the treatment of stage IV non-small cell lung cancer

– a phase II randomised clinical and translational trial
- EudraCT number: 2021-003266
Background/study objectives |
Study design |
Collaborative partners |
Update/publications |